Michel Kazatchkine

Last updated
Kazatchkine at "AIDS 2012" sponsored by the International AIDS Society Michel Kazatchkine 2012.jpg
Kazatchkine at "AIDS 2012" sponsored by the International AIDS Society

Michel Kazatchkine is a French physician, diplomat and advocate who is best known for his work in international AIDS treatment issues. From February 2007 to March 2012 he was director of The Global Fund to Fight AIDS, Tuberculosis and Malaria. On July 20, 2012, UN Secretary-General Ban Ki-moon appointed him as his United Nations Special Envoy for HIV/AIDS in Eastern Europe and Central Asia. [1]

Contents

Kazatchkine is also a Senior Fellow with the Global Health Program of the Graduate Institute of International and Development Studies in Geneva, and a member of the Global Commission on Drug Policy.

Early life and education

Kazatchkine graduated medical school at Necker-Enfants Malades Hospital in Paris then studied immunology at the Pasteur Institute.

Career

Kazatchkine first treated AIDS patients in 1983, and by 1985 had founded a clinic in Paris specializing in AIDS treatment. [2]

Kazatchkine directed the French National Agency for AIDS Research between 1998 and 2005. He is a member of Médecins du Monde and one of the founders of Nova Dona, which is a non-profit organization giving services to drug users in Paris. [2]

In 2004-2007 Kazatchkine served as a Chair of the World Health Organization's Strategic and Technical Advisory Committee on HIV/AIDS and as a member of the WHO's Scientific and Technical Advisory Group on tuberculosis. [2] In February 2005 he also became France's HIV/AIDS and communicable diseases global ambassador and served in this role until 2007. [2]

From 2005 until 2006 Kazatchkine served The Global Fund to Fight AIDS, Tuberculosis and Malaria as a vice chair. He became the organization's director in 2007, [2] succeeding Richard Feachem. [3] During his time in office, a pledging conference in 2010 raised less than its lowest target of $13 billion over three years. Also, Kazatchkine became the target of allegations of favouritism in funding a HIV awareness campaign co-ordinated by friends of Carla Bruni-Sarkozy, whom he named as the fund's first global Aids ambassador; the charges were later investigated and found baseless by the Fund's board. [4] [5] In late 2011, the Fund's board appointed a general manager to oversee day-to-day operations and a new transition plan, effectively reducing Kazatchkine's role to that of chief fund-raiser and public advocate. [6] In January 2012 the Global Fund officially announced that Kazatchkine will step down in March 2012. [7]

Since 2020, Kazatchkine has been serving as a member of the Independent Panel for Pandemic Preparedness and Response (IPPR), an independent group examining how the WHO and countries handled the COVID-19 pandemic, co-chaired by Helen Clark and Ellen Johnson Sirleaf. [8]

Other activities

Related Research Articles

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

<span class="mw-page-title-main">Tropical medicine</span> Interdisciplinary branch of medicine

Tropical medicine is an interdisciplinary branch of medicine that deals with health issues that occur uniquely, are more widespread, or are more difficult to control in tropical and subtropical regions.

<span class="mw-page-title-main">The Global Fund to Fight AIDS, Tuberculosis and Malaria</span> International organization

The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing and partnership organization that aims to "attract, leverage and invest additional resources to end the epidemics of HIV/AIDS, tuberculosis and malaria to support attainment of the Sustainable Development Goals established by the United Nations". This multistakeholder international organization maintains its secretariat in Geneva, Switzerland. The organization began operations in January 2002. Microsoft founder Bill Gates was one of the first donors to provide seed money for the partnership. From January 2006 it has benefited from certain US Privileges, Exemptions, and Immunities under executive order 13395, which conferred International Organizations Immunities Act status on it.

The European and Developing Countries Clinical Trials Partnership (EDCTP) is a partnership between the European Union (EU), Norway, Switzerland and developing countries and other donors, as well as the pharmaceutical industry, to enable clinical trials and the development of new medicines and vaccines against HIV/AIDS, tuberculosis, and malaria. The need for global action against these diseases in order to promote poverty reduction has been recognised by the United Nations, the G8, and the African Union, and the program envisioned the provision of €600 million for the period 2003–2007 in order to translate medical research results into clinical applications relevant to the needs of developing countries.

<span class="mw-page-title-main">Alan Aderem</span> American biologist

Alan Aderem is an American biologist, specializing in immunology and cell biology. Aderem's particular focus is the innate immune system, the part of the immune system that responds generically to pathogens. His laboratory's research focuses on diseases afflicting citizens of resource poor countries, including AIDS, malaria, tuberculosis and influenza.

<span class="mw-page-title-main">PATH (global health organization)</span> Global health nonprofit

PATH is an international, nonprofit global health organization. PATH is based in Seattle with 1,600 employees in more than 70 countries around the world. Its president and CEO is Nikolaj Gilbert, who is also the Managing Director and CEO of Foundations for Appropriate Technologies in Health (FATH), PATH's Swiss subsidiary. PATH focuses on six platforms: vaccines, drugs, diagnostics, devices, system, and service innovations.

<span class="mw-page-title-main">Awa Marie Coll-Seck</span> Senegalese infectious diseases specialist and politician

Awa Marie Coll-Seck is as Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.

<span class="mw-page-title-main">Margaret Hamburg</span> American public health administrator (born 1955)

Margaret Ann "Peggy" Hamburg is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.

<span class="mw-page-title-main">Wafaa El-Sadr</span> Egyptian physician

Wafaa El-Sadr is a Columbia University Professor and the director of ICAP at Columbia University, Columbia World Projects and the Center for Infectious Disease Epidemiologic Research (CIDER) at Columbia Mailman School of Public Health.

<span class="mw-page-title-main">Agnes Binagwaho</span> Rwandan pediatrician

Agnes Binagwaho is a Rwandan pediatrician and co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She resides in Kigali.

<span class="mw-page-title-main">Peter Sands (banker)</span>

Peter Alexander Sands is a British banker, and the executive director of the Global Fund to fight AIDS, Tuberculosis and Malaria. He was the chief executive (CEO) of Standard Chartered from November 2006 to June 2015.

The Medicines Patent Pool (MPP) is a Unitaid-backed international organisation founded in July 2010, based in Geneva, Switzerland. Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling. Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries (LMIC). In May 2020, the MPP become an implementing partner of the WHO's Covid-19 Technology Access Pool (C-TAP).

<span class="mw-page-title-main">Salim Abdool Karim</span> South African medical researcher

Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc) is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives

Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.

This page is a timeline of global health, including major conferences, interventions, cures, and crises.

<span class="mw-page-title-main">Global AIDS and Tuberculosis Relief Act of 2000</span> US law

Global AIDS and Tuberculosis Relief Act of 2000 or Global AIDS Research and Relief Act of 2000 is a United States federal law establishing the World Bank AIDS Trust Fund for the care and prevention of HIV/AIDS and tuberculosis in overseas continents supporting substantial populations. The Act of Congress endorsed the International Bank for Reconstruction and Development and International Development Association to govern the financial fund for the global opportunistic infection epidemics.

Francine NtoumiPh.D., HDR, PvDz, FRCPedin is a Congolese parasitologist specializing in malaria. She was the first African person in charge of the secretariat of the Multilateral Initiative on Malaria (2006-2010). In recent years, she has become involved in research on other infectious diseases, including COVID-19.

Robert Michael Hecht is an American global health policy and financing expert. Hecht is currently Founder and President of Pharos Global Health Advisors. He has previously held positions with the World Bank, UNAIDS, the International AIDS Vaccine Initiative, and Results for Development Institute. He serves as a lecturer at Yale University’s Jackson Institute for Global Affairs and is a clinical professor at the Yale School of Public Health. He has published on a range of topics in global health and development, with a special focus on the economics, financing, and policies for infectious diseases, nutrition, and broader health system reform. He has been an advisor to the President's Emergency Plan for AIDS Relief (PEPFAR), the World Health Organization, and UNITAID. Hecht holds a BA from Yale and a PhD from Cambridge University.

Dr. Winnie Mpanju-Shumbusho is a Tanzanian paediatrician and public health leader who until December 31, 2015, served as World Health Organization (WHO) Assistant Director General for HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases based in Geneva, Switzerland. From 2016 to 2019, she served as board chair of RBM Partnership To End Malaria. Before joining WHO in 1999, Mpanju-Shumbusho was Director General of The East, Central and Southern African Health Community (ECSA-HC) formerly known as the Commonwealth Regional Health Community for East, Central and Southern Africa (CRHC-ECSA).

<span class="mw-page-title-main">John La Montagne</span> Mexican-American biomedical scientist (1943–2004)

John Ring La Montagne was a Mexican-American biomedical scientist who served as the deputy director of the National Institute of Allergy and Infectious Diseases from 1998 to 2004. He specialized in viral vaccines, HIV/AIDS research, and oversaw NIH's biodefense research after the September 11 attacks.

References

  1. ↑ UN Press Release
  2. 1 2 3 4 5 "MICHEL KAZATCHKINE". theglobalfund.org. The Global Fund to Fight AIDS, Tuberculosis and Malaria. Archived from the original on 27 September 2011. Retrieved 7 July 2011.
  3. ↑ Donald G. McNeil Jr. (February 9, 2007), France: French Doctor to Lead Global Disease Fund New York Times .
  4. ↑ Global Fund concerned about funding targets Reuters , July 20, 2009.
  5. ↑ Andrew Jack (January 24, 2012), Global diseases agency forces chief to quit Financial Times .
  6. ↑ Donald G. McNeil Jr. (January 24, 2012), Director Quits After Changes at Global Fund New York Times .
  7. ↑ The Global Fund (24 January 2012). "THE GLOBAL FUND'S EXECUTIVE DIRECTOR TO STEP DOWN IN MARCH". Archived from the original on 1 February 2012. Retrieved 30 January 2012.
  8. ↑ Stephanie Nebehay and Kate Kelland (September 3, 2020), Pandemic review panel named, includes Miliband, ex Mexican president Reuters .
  9. ↑ Global Health Centre International Advisory Board Graduate Institute of International and Development Studies, press release of April 20, 2020.
  10. ↑ Advisory Board on Global Drug Policy Open Society Foundations (OSF).
  11. ↑ Board Tuberculosis Vaccine Initiative (TBVI).
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.